CELGENE CORPORATION et al V. ACTAVIS SOUTH ATLANTIC LLC > Summary
Court Case Number 2:11-cv-02162
Filing Date Apr 15, 2011
Court New Jersey District Court
Status Unknown
Defendant
Plaintiff Attorneys
8Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
NOVARTIS PHARMA AG
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Novartis
Attorney Name: Charles M. Lizza
Saul Ewing LLP
NOVARTIS PHARMA AG
Attorney Name: William J. O'Shaughnessy
McCarter & English
Novartis
Attorney Name: William J. O'Shaughnessy
McCarter & English
NOVARTIS PHARMA AG
Attorney Name: Jonathan M.h. Short
McCarter & English
Novartis
Attorney Name: Jonathan M.h. Short
McCarter & English
Defendant Attorneys
Counter Defendant
4Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
NOVARTIS PHARMA AG
Attorney Name: William J. O'Shaughnessy
McCarter & English
Novartis
Attorney Name: William J. O'Shaughnessy
McCarter & English
Counter Claimant
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07431944 | Delivery of multiple doses of medications | Oct 7, 2008 |
| 06635284 | Delivery of multiple doses of medications | Oct 21, 2003 |
| 06528530 | Phenidate drug formulations having diminished abuse potential | Mar 4, 2003 |
| 06355656 | Phenidate drug formulations having diminished abuse potential | Mar 12, 2002 |
| 05908850 | Method of treating attention deficit disorders with d-threo methylphenidate | Jun 1, 1999 |
| 05837284 | Delivery of multiple doses of medications | Nov 17, 1998 |
